title: Thrombophilia testing, recurrent thrombosis, and women's health.
authors.affiliation: From the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. gpiazza@partners.org.
authors.forename: Gregory
authors.initials: G
authors.lastname: Piazza
mesh_terms: D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening; D009025:Morpholines / Q000627:therapeutic use; D009154:Mutation / Q000235:genetics; D011516:Prothrombin / Q000235:genetics; D012008:Recurrence; D012307:Risk Factors; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use; D019851:Thrombophilia / Q000150:complications* / Q000175:diagnosis* / Q000235:genetics; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D014859:Warfarin / Q000627:therapeutic use; D016387:Women's Health
chemical_list: D000925:Anticoagulants; D009025:Morpholines; D013876:Thiophenes; D014859:Warfarin; D011516:Prothrombin; D000069552:Rivaroxaban